Herpesvirus infection of placenta may be harmful in pregnancy leading to disorders in fetal growth, premature delivery, miscarriage, or major congenital abnormalities.
Intrauterine herpesvirus infection may be associated with pathological conditions, such as disturbances in fetal growth, premature delivery, miscarriage, or major congenital abnormalities.
Women were classified as initiating HAART before, during, or after first pregnancy while in care if they started first HAART ≥30 days before estimated date of conception (DOC), <30 days before DOC and ≤30 days after pregnancy event (defined as delivery, miscarriage, or pregnancy termination), or >30 days after pregnancy event, respectively.
Following preterm delivery, miscarriage was significantly associated with HIV positivity (OR: 1.37; CI: 1.1 2.3).
In pregnant women, serious maternal fetal infections can occur, resulting in preterm delivery, miscarriage, or stillbirth.
No other sociodemographic or clinical characteristics (age, residence, history of home delivery, miscarriage, dental manipulation, surgery, and blood transfusion) were significantly associated with HBsAg or anti-HCV seropositivity.
No other sociodemographic or clinical characteristics (history of home delivery, miscarriage, dental manipulation, surgery, traditional scar and blood transfusion) were significantly associated with HBsAg (Table 2).
Gestational trophoblastic disease (GTD) is a rare gynecological disease and contains a series of pregnancy-related disorders, which occurs in the delivery, miscarriage, or termination of pregnancy.
Other sociodemographic or clinical characteristics (age, residence, history of home delivery, miscarriage, circumcision, dental manipulation) were not significantly associated with anti-HCV seropositivity (Table 3).
There is no link between HPV and premature deliveries, miscarriages or other pregnancy complications.
